NEOG
NASDAQNeogen Corporation
Website
News25/Ratings5
News · 26 weeks59+200%
2025-10-262026-04-19
Mix1890d
- Insider6(33%)
- Other5(28%)
- SEC Filings4(22%)
- Earnings2(11%)
- Leadership1(6%)
Latest news
25 items- PRNeogen's Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ CertificationNeogen® Corporation (NASDAQ:NEOG), an innovative leader in food safety solutions, today announced that its Molecular Detection Assay - Listeria Right Now™ rapid environmental monitoring test has received AOAC® Performance Tested Methods℠ (PTM) certification (No. 042604), validating the test's performance for the enrichment-free detection of viable and non-viable Listeria species on stainless steel surfaces. The technology allows technicians to perform the assay without first enriching the sample by growing the bacteria in culture media. Combined with the ease-of-use and speed advantages associated with Neogen's Molecular Detection System ™, this makes Neogen's test one of the fastest molecu
- SECNeogen Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - NEOGEN CORP (0000711377) (Filer)
- INSIDERSEC Form 3 filed by new insider Stacey Jennifer Evans3 - NEOGEN CORP (0000711377) (Issuer)
- SECSEC Form 10-Q filed by Neogen Corporation10-Q - NEOGEN CORP (0000711377) (Filer)
- SECNeogen Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - NEOGEN CORP (0000711377) (Filer)
- PRNeogen Reports Third Quarter Fiscal Year 2026 Financial ResultsFiscal third quarter 2026 revenue of $211.2 million Food Safety revenue growth of 2.6%, Core Growth1 of 4.0%; Animal Safety revenue growth of (20.1%), Core Growth1 of (8.7%) due primarily to third-party supplier challenges in the quarter Net loss of $17.0 million in the third quarter 2026 with GAAP EPS of $(0.08), Adjusted Net Income of $19.4 million and Adjusted EPS of $0.09 Third quarter 2026 cash flow from operations of $22.7 million and free cash flow of $11.1 million Adjusted EBITDA1 of $48.2 million; Adjusted EBITDA margins1 of 22.8% increases sequentially by 110 basis points Petrifilm® manufacturing transition remains on track for November FY27; Company has initiated
- PRNeogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board SecretaryNeogen Corporation (NASDAQ:NEOG), an innovative leader in food safety solutions, today announced the appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary. Ms. Stacey is an accomplished chief legal and compliance officer and board secretary with extensive experience in the life sciences industry. She has served more than 10 years as a public company chief legal and compliance officer and board secretary, as well as five years as a public company board member. Over her more than 25-year career, she has led legal, compliance, government relations, corporate communications and human resources functions, operating in complex, fast-moving environments.
- SECNeogen Corporation filed SEC Form 8-K: Leadership Update8-K - NEOGEN CORP (0000711377) (Filer)
- PRNeogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026Neogen® Corporation (NASDAQ:NEOG) will issue its third-quarter earnings release before the opening of the market on Thursday, April 9, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time. During the call, Neogen management will provide a financial overview and business update of the company's performance for the third-quarter of fiscal year 2026. The conference call can be accessed by dialing: Toll-Free - North America: (1) 888-660-6264 International: (+1) 646-517-3975 Conference ID: 70064# The live webcast can be accessed through Neogen's Investor Relations webpage, neogen.com/investor-relations, under the "E
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Neogen CorporationSCHEDULE 13G/A - NEOGEN CORP (0000711377) (Subject)
- PRNeogen Announces Sale of Genomics Business to ZoetisNeogen Corporation (NASDAQ:NEOG), an innovative leader in food safety solutions, announced today it has entered into a definitive agreement to sell its global genomics business to Zoetis Inc. ("Zoetis"), the world's leading animal health company, for $160 million, subject to customary closing adjustments. The planned divestiture, which had been previously announced, was part of the company's portfolio review strategy to simplify the business and focus on core strategic markets. The transaction is expected to close by the end of the first half of the Company's 2027 fiscal year, subject to regulatory approval and customary closing conditions. The net proceeds from the transaction are expected
- PRZoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health InnovationAcquisition strengthens Zoetis' leadership in Precision Animal Health by integrating Neogen's global genomics capabilities, expanding predictive insights and individualized care worldwide Zoetis Inc. (NYSE:ZTS) the world's leading animal health company, today announced it has entered into a definitive agreement with Neogen Corporation (NASDAQ:NEOG) ("Neogen") to acquire Neogen's animal genomics business for $160 million, subject to customary closing adjustments. This acquisition aligns directly with Zoetis' strategy to drive future livestock innovation through genomics, reinforcing its commitment to livestock producers worldwide and advancing its Precision Animal Health portfolio. By inte
- INSIDERCEO Nassif Mikheal bought $252 worth of shares (23 units at $10.94) (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERCEO Nassif Mikheal bought $486 worth of shares (49 units at $9.93) (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERAmendment: Senior Vice President Ranalli Tamara A. was granted 101,626 shares (SEC Form 4)4/A - NEOGEN CORP (0000711377) (Issuer)
- PRNeogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile SolutionNeogen Corporation (NASDAQ:NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following intraarticular injections of this product, which is inconsistent with its labeled, intended use. To date, Neogen has not received reports of adverse events when used in a manner consistent with the labeled use. While the company's
- INSIDERSenior Vice President Ranalli Tamara A. was granted 50,813 shares (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERSEC Form 3 filed by new insider Ranalli Tamara A.3 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERCEO Nassif Mikheal bought $1,279 worth of shares (137 units at $9.33) (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- SECSEC Form 10-Q filed by Neogen Corporation10-Q - NEOGEN CORP (0000711377) (Filer)
- SECNeogen Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - NEOGEN CORP (0000711377) (Filer)
- PRNeogen Announces Second-Quarter 2026 ResultsRevenue of $224.7 million, a decrease of 2.8% YoY; Core growth1 increased 2.9% YoY Net loss of $15.9 million; Adjusted Net Income1 of $22.6 million Adjusted EBITDA1 of $48.7 million; Adjusted EBITDA margin1 increased 470 bps sequentially Company hires key senior commercial leaders Petrifilm manufacturing transition remains on track Raising FY 2026 revenue and Adjusted EBITDA guidance 1 Non-GAAP financial measures; see explanations and reconciliations that follow Neogen Corporation (NASDAQ:NEOG) announced today the results of the second quarter ended November 30, 2025. "I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic tr
- PRNeogen® Announces Two Senior Leadership AppointmentsNeogen Corporation (NASDAQ:NEOG) today announced the appointments of Joe Freels as Senior Vice President and Chief Commercial Officer, effective January 5, 2026, and Dr. Tammi Ranalli as Senior Vice President and General Manager, Global Food Safety, effective January 7, 2026. As Senior Vice President and General Manager for Neogen's Food Safety business unit, Dr. Ranalli will have full P&L responsibility for Neogen's global Food Safety portfolio and will develop and execute the global strategy for continued innovation and growth, including marketing, research and development, and government and regulatory affairs. She joins Neogen from QuidelOrtho, where she served as Senior Vice Presiden
- PRNeogen Announces Second-Quarter Earnings Release DateNeogen® Corporation (NASDAQ:NEOG) will issue its second-quarter earnings release before the opening of the market on January 8, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-800-549-8228 International: (+1) 646-564-2877 Conference ID: 82072 The live webcast can be accessed through Neogen's Investor Relations webpage, investors.neogen.com, under the "Events & Presentations" subheading. A replay of the conference call and webcast will be available shortly following the conclusion of the call and c
- PRNeogen® To Participate in Upcoming Investor ConferencesNeogen® Corporation (NASDAQ:NEOG) announced today that the Company will participate in two upcoming investor conferences. The Company will participate in the CJS Securities 26th Annual New Ideas for the New Year conference, held virtually on January 14, 2026. The Company will also participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, where Mike Nassif, Neogen's President and CEO, will present on January 14, 2026, at 5:15 PM Pacific time. The live webcasts can be accessed through Neogen's Investor Relations webpage, investors.neogen.com, under the "Events & Presentations" subheading. About Neogen Neogen Corporation is committed to fueling a brigh